44
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome‐Mediated Mechanism

      research-article
      , MD 1 , 3 , , MD 1 , 3 , , MD 1 , 2 , , MD 1 , , MD, PhD 1 , , MD, PhD 3 , , MD, PhD 1 , , MD 1 , , MD, PhD 1 , , MD 1 , , MD 3 , , MD 3 , , MD 3 , 5 , , MD, PhD 3 , , PhD 4 , , MD 3 , , MD, PhD 3 , 5 , , PhD 3 , , MD, PhD 3 , , , MD 1 ,
      Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
      John Wiley and Sons Inc.
      cardiovascular risk factor, endothelial dysfunction, exosomes, Helicobacter pylori, Vascular Disease, Atherosclerosis, Endothelium/Vascular Type/Nitric Oxide

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Epidemiological studies have suggested an association between Helicobacter pylori ( H pylori) infection and atherosclerosis through undefined mechanisms. Endothelial dysfunction is critical to the development of atherosclerosis and related cardiovascular diseases. The present study was designed to test the hypothesis that H pylori infection impaires endothelial function through exosome‐mediated mechanisms.

          Methods and Results

          Young male and female patients (18‐35 years old) with and without H pylori infection were recruited to minimize the chance of potential risk factors for endothelial dysfunction for the study. Endothelium‐dependent flow‐mediated vasodilatation of the brachial artery was evaluated in the patients and control subjects. Mouse infection models with CagA + H pylori from a gastric ulcer patient were created to determine if H pylori infection‐induced endothelial dysfunction could be reproduced in animal models. H pylori infection significantly decreased endothelium‐dependent flow‐mediated vasodilatation in young patients and significantly attenuated acetylcholine‐induced endothelium‐dependent aortic relaxation without change in nitroglycerin‐induced endothelium‐independent vascular relaxation in mice. H pylori eradication significantly improved endothelium‐dependent vasodilation in both patients and mice with H pylori infection. Exosomes from conditioned media of human gastric epithelial cells cultured with CagA + H pylori or serum exosomes from patients and mice with H pylori infection significantly decreased endothelial functions with decreased migration, tube formation, and proliferation in vitro. Inhibition of exosome secretion with GW4869 effectively preserved endothelial function in mice with H pylori infection.

          Conclusions

          H pylori infection impaired endothelial function in patients and mice through exosome‐medicated mechanisms. The findings indicated that H pylori infection might be a novel risk factor for cardiovascular diseases.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Endothelial cell metabolism in normal and diseased vasculature.

          Higher organisms rely on a closed cardiovascular circulatory system with blood vessels supplying vital nutrients and oxygen to distant tissues. Not surprisingly, vascular pathologies rank among the most life-threatening diseases. At the crux of most of these vascular pathologies are (dysfunctional) endothelial cells (ECs), the cells lining the blood vessel lumen. ECs display the remarkable capability to switch rapidly from a quiescent state to a highly migratory and proliferative state during vessel sprouting. This angiogenic switch has long been considered to be dictated by angiogenic growth factors (eg, vascular endothelial growth factor) and other signals (eg, Notch) alone, but recent findings show that it is also driven by a metabolic switch in ECs. Furthermore, these changes in metabolism may even override signals inducing vessel sprouting. Here, we review how EC metabolism differs between the normal and dysfunctional/diseased vasculature and how it relates to or affects the metabolism of other cell types contributing to the pathology. We focus on the biology of ECs in tumor blood vessel and diabetic ECs in atherosclerosis as examples of the role of endothelial metabolism in key pathological processes. Finally, current as well as unexplored EC metabolism-centric therapeutic avenues are discussed. © 2015 American Heart Association, Inc.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction.

            Sepsis is an infection-induced severe inflammatory disorder that leads to multiple organ failure. Amongst organs affected, myocardial depression is believed to be a major contributor to septic death. While it has been identified that large amounts of circulating pro-inflammatory cytokines are culprit for triggering cardiac dysfunction in sepsis, the underlying mechanisms remain obscure. Additionally, recent studies have shown that exosomes released from bacteria-infected macrophages are pro-inflammatory. Hence, we examined in this study whether blocking the generation of exosomes would be protective against sepsis-induced inflammatory response and cardiac dysfunction. To this end, we pre-treated RAW264.7 macrophages with GW4869, an inhibitor of exosome biogenesis/release, followed by endotoxin (LPS) challenge. In vivo, we injected wild-type (WT) mice with GW4869 for 1h prior to endotoxin treatment or cecal ligation/puncture (CLP) surgery. We observed that pre-treatment with GW4869 significantly impaired release of both exosomes and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in RAW264.7 macrophages. At 12h after LPS treatment or CLP surgery, WT mice pre-treated with GW4869 displayed lower amounts of exosomes and pro-inflammatory cytokines in the serum than control PBS-injected mice. Accordingly, GW4869 treatment diminished the sepsis-induced cardiac inflammation, attenuated myocardial depression and prolonged survival. Together, our findings indicate that blockade of exosome generation in sepsis dampens the sepsis-triggered inflammatory response and thereby, improves cardiac function and survival.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Extracellular vesicles: structure, function, and potential clinical uses in renal diseases

              Interest in the role of extracellular vesicles in various diseases including cancer has been increasing. Extracellular vesicles include microvesicles, exosomes, apoptotic bodies, and argosomes, and are classified by size, content, synthesis, and function. Currently, the best characterized are exosomes and microvesicles. Exosomes are small vesicles (40-100 nm) involved in intercellular communication regardless of the distance between them. They are found in various biological fluids such as plasma, serum, and breast milk, and are formed from multivesicular bodies through the inward budding of the endosome membrane. Microvesicles are 100-1000 nm vesicles released from the cell by the outward budding of the plasma membrane. The therapeutic potential of extracellular vesicles is very broad, with applications including a route of drug delivery and as biomarkers for diagnosis. Extracellular vesicles extracted from stem cells may be used for treatment of many diseases including kidney diseases. This review highlights mechanisms of synthesis and function, and the potential uses of well-characterized extracellular vesicles, mainly exosomes, with a special focus on renal functions and diseases.
                Bookmark

                Author and article information

                Contributors
                liuzheng@health.missouri.edu
                xucanxia2000@163.com
                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                10.1002/(ISSN)2047-9980
                JAH3
                ahaoa
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                John Wiley and Sons Inc. (Hoboken )
                2047-9980
                15 March 2020
                17 March 2020
                : 9
                : 6 ( doiID: 10.1002/jah3.v9.6 )
                : e014120
                Affiliations
                [ 1 ] Departments of Gastroenterology Third Xiangya Hospital, Central South University Changsha China
                [ 2 ] Departments of Cardiology Third Xiangya Hospital, Central South University Changsha China
                [ 3 ] Center for Precision Medicine and Division of Cardiovascular Medicine University of Missouri School Columbia MO
                [ 4 ] Department of Physiology and Pharmacology University of Calgary Alberta Canada
                [ 5 ] Division of Stem Cell Regulation and Application Hunan University of Chinese Medicine Changsha China
                Author notes
                [*] [* ] Correspondence to: Canxia Xu, MD, Department of Gastroenterology, Third Xiangya Hospital of Central South University, Tongzipo Road 138, Changsha 410013, Hunan, China. E‐mail: xucanxia2000@ 123456163.com

                and

                Zhenguo Liu, MD, PhD, Division of Cardiovascular Medicine, Center for Precision Medicine, Department of Medicine, University of Missouri School of Medicine, 1 Hospital Drive, CE306, Columbia, MO 65212. E‐mail: liuzheng@ 123456health.missouri.edu .

                Author information
                https://orcid.org/0000-0002-9917-6684
                Article
                JAH34919
                10.1161/JAHA.119.014120
                7335532
                32174233
                fbe10de5-c411-4fba-ac6f-b2f2b9cd91d6
                © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 01 November 2019
                : 07 February 2020
                Page count
                Figures: 5, Tables: 1, Pages: 15, Words: 9147
                Funding
                Funded by: National Natural Scientific Foundation of China
                Award ID: 81570509
                Funded by: Hunan Natural Science Foundation of China
                Award ID: 2018JJ6136
                Funded by: Third Xiangya Hospital of Central South University
                Award ID: 20150310
                Funded by: US NIH
                Award ID: HL148196
                Award ID: ES026200
                Categories
                Original Research
                Original Research
                Vascular Medicine
                Custom metadata
                2.0
                17 March 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.8 mode:remove_FC converted:17.03.2020

                Cardiovascular Medicine
                cardiovascular risk factor,endothelial dysfunction,exosomes,helicobacter pylori,vascular disease,atherosclerosis,endothelium/vascular type/nitric oxide

                Comments

                Comment on this article